Klein K L, Anderson S, Ferguson J, Rogers K, Cintron G
J Fla Med Assoc. 1989 Mar;76(3):311-5.
Cardiac transplantation has evolved from an experimental procedure to an accepted mode of therapy that prolongs life in patients with severe heart failure. The University of South Florida-Tampa General Hospital began performing cardiac transplantation for the treatment of end-stage cardiac disease in June 1985. Since then 42 heart transplantations have been performed and 30 patients are alive and well. The one-year actuarial survival is 78.73% and the two-year actuarial survival is 72.15%. Multiple complications have been encountered most notably rejection and infection. The recent approval of the USF/TGH program as a Medicare funded cardiac transplantation center is expected to greatly expand the number of potential recipients and will provide the residents of Florida, and the Southeastern United States, with an additional health care resource.
心脏移植已从一种实验性手术发展成为一种被认可的治疗方式，可延长重症心力衰竭患者的生命。南佛罗里达大学坦帕总医院于1985年6月开始进行心脏移植手术，用于治疗终末期心脏病。自那时起，已进行了42例心脏移植手术，30名患者存活且状况良好。一年实际生存率为78.73%，两年实际生存率为72.15%。出现了多种并发症，最显著的是排斥反应和感染。南佛罗里达大学/坦帕总医院项目最近获批成为由医疗保险资助的心脏移植中心，预计这将大幅增加潜在受者的数量，并为佛罗里达州以及美国东南部的居民提供额外的医疗资源。
